USP29 and breast carcinoma: As shown in Figure 3D–F; Figure S3J–L (Supporting Information), the knockdown of USP29 in MDA‐MB‐231 and BT549 cells mitigated the size and number of mammosphere and the percentage of CD44+/CD24− cell, a known marker of CSC subpopulation in breast cancer.